October 3, 2023 02:53 PM EDT
Pharma
FDA+
Coronavirus

FDA clears No­vavax’s fall boost­er for Covid-19, weeks af­ter mR­NA vac­cine boost­ers 

Nicole DeFeudis

Editor

The FDA cleared No­vavax’s up­dat­ed Covid-19 boost­er for the fall sea­son on Tues­day, weeks af­ter mR­NA boost­ers se­cured an au­tho­riza­tion.

No­vavax made clear last month …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PureTech CEO leaves just one week af­ter long­time chair steps down

Prime Med­i­cine CSO de­parts, re­veals new fund­ing; FDA lifts par­tial hold on Kezar drug

RFK reshuf­fles top HHS lead­er­ship, re­plac­ing his chief of staff and an­oth­er top aide

Jeanne Mar­raz­zo, NI­AID di­rec­tor placed on leave, on 'biggest threat­s' to HIV med­i­cine

Up­dat­ed: FDA pub­lish­es repos­i­to­ry of 200+ drug re­jec­tion let­ters, promis­ing more in the fu­ture

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

A service from the Financial Times